Featured Research

from universities, journals, and other organizations

New test makes Parkinson's-like disorder of middle age detectable in young adulthood

Date:
April 1, 2014
Source:
University of California - Davis Health System
Summary:
The very earliest signs of a debilitating neurodegenerative disorder, in which physical symptoms are not apparent until the fifth decade of life, are detectable in individuals as young as 30 years old using a new, sophisticated type of neuroimaging, researchers have found. People with the condition -- fragile X-associated tremor/ataxia syndrome (FXTAS) -- experience tremors, poor balance, cognitive impairments and Parkinsonism. The genetic condition results from a mutation in the fragile X mental retardation gene (FMR1).

The very earliest signs of a debilitating neurodegenerative disorder, in which physical symptoms are not apparent until the fifth decade of life, are detectable in individuals as young as 30 years old using a new, sophisticated type of neuroimaging, researchers at UC Davis, the University of Illinois and UCLA have found.

Related Articles


People with the condition -- fragile X-associated tremor/ataxia syndrome (FXTAS) -- experience tremors, poor balance, cognitive impairments and Parkinsonism. The genetic condition results from a mutation in the fragile X mental retardation gene (FMR1). FXTAS develops in about 40 percent of male and 15 percent of female carriers of the mutated FMR1 gene.

"Our findings suggest that the brain abnormalities of FXTAS may begin to develop about two decades before symptoms might occur," said Tony J. Simon, study senior author and professor, Department of Psychiatry and Behavioral Sciences.

"Altered Structural Brain Connectome in Young Adult Fragile X Premutation Carriers," is published in Human Brain Mapping.

The study included 88 participants, between age 20 and 40. Of these, 46 were symptomless carriers of the FMR1 gene mutation (fXPCs). They were matched by age and gender with 42 healthy individuals without the gene mutation. IQ test results did not differ between the fXPCs and controls.

In males, it found a correlation between the efficiency of a healthy male carrier's brain network and the extent of his gene mutation. The correlation may prove to be an effective marker of early brain aging in neurologically symptomless fXPCs. The study also revealed that the volume of the brain stem is smaller in male fXPCS than in male controls.

In a novel finding, among the female participants, researchers detected volume differences in several brain areas of female fXPCs and female controls.

"These suggest the presence of compensatory mechanisms in neurologically symptomless females but not in similar male carriers of the gene mutation," said Simon, a researcher affiliated with the UC Davis MIND Institute.

Despite the absence of any clinical symptoms of FXTAS, the male and female gene mutation carriers performed significantly worse in several tests when compared to unaffected controls, Simon said.

"Given the lower risk for FXTAS or related neurological symptoms in female fXPCs, we were surprised to find such differences when their minds and brains were compared with those of the unaffected female controls," he said.

Both groups were evaluated by cognitive testing as well as novel neuroimaging techniques termed "brain connectomics," based on diffusion tensor imaging (DTI) whole-brain tractography. A connectome is a comprehensive map, like a wiring diagram, of neural connections in the brain. The methods used were partly developed by study first author Alex Leow of the University of Illinois, Chicago. The investigation is the first-ever connectome study using DTI-whole brain tractography to compare fXPCs and controls.

The technology allowed Simon and his collaborators to conduct a system-wide investigation of the connections between the brain's grey matter, which is involved in movement control, sensory perception, memory, emotions, speech, decision-making and self-control, and the white matter structures that transmit the signals that underlie these actions and behaviors.

The study suggests that combining analyses of cognitive function, clinical data and connectome patterns in premutation carriers may be more effective ways to characterize an individual's underlying brain pathophysiology, and possibly assessing risks for later degeneration, than is possible using current methods.

In addition to FXTAS, the fragile X-associated disorders include fragile X syndrome, the most common form of intellectual disability in children, and fragile X-associated primary ovarian insufficiency (FXPOI).

"Identifying these brain changes when the individuals who carry the gene mutation are young is important because there are medical interventions that can help them avoid or reduce their symptoms," said MIND Institute Medical Director Randi Hagerman.


Story Source:

The above story is based on materials provided by University of California - Davis Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Alex Leow, Danielle Harvey, Naomi J. Goodrich-Hunsaker, Johnson Gadelkarim, Anand Kumar, Liang Zhan, Susan M. Rivera, Tony J. Simon. Altered structural brain connectome in young adult fragile X premutation carriers. Human Brain Mapping, 2014; DOI: 10.1002/hbm.22491

Cite This Page:

University of California - Davis Health System. "New test makes Parkinson's-like disorder of middle age detectable in young adulthood." ScienceDaily. ScienceDaily, 1 April 2014. <www.sciencedaily.com/releases/2014/04/140401102705.htm>.
University of California - Davis Health System. (2014, April 1). New test makes Parkinson's-like disorder of middle age detectable in young adulthood. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2014/04/140401102705.htm
University of California - Davis Health System. "New test makes Parkinson's-like disorder of middle age detectable in young adulthood." ScienceDaily. www.sciencedaily.com/releases/2014/04/140401102705.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins